This episode explores the critical role of **lactate metabolism** as a biomarker for assessing organ quality in **Donation after Circulatory Death (DCD)** compared to **Donation after Brain Death (DBD)**. While the heart typically consumes lactate and the liver clears it, the **warm ischemia** inherent in DCD causes a shift toward anaerobic metabolism and significant lactate accumulation. To mitigate this injury, advanced **ex vivo perfusion** and **normothermic regional perfusion** techniques are utilized to monitor **lactate clearance trends** as a primary indicator of graft viability. While absolute thresholds exist, such as specific millimole targets for livers and hearts, the **downward trajectory** of lactate levels during perfusion is a more reliable predictor of post-transplant success. Clinical data suggest that when these metabolic markers are managed effectively, DCD organs can achieve **survival outcomes** comparable to traditional DBD grafts. Ultimately, the conversation highlights how **metabolic monitoring** transforms high-risk donor organs into viable options for transplantation.